MannKind and Monte Rosa Therapeutics List on Nasdaq Exchange
1 report, 1 independent
Updated Thu 00:00
AI-generated briefing. Brind wrote this from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
MannKind Corporation and Monte Rosa Therapeutics were both listed on the Nasdaq stock exchange on October 15, 2026. The companies are both classified as small-cap healthcare firms.
From dailypolitical.com
Why it matters
A comparison of the two companies showed that Monte Rosa Therapeutics has a stronger consensus analyst rating and a higher potential upside compared to MannKind Corporation. Monte Rosa Therapeutics also has higher institutional ownership, at 80.0%, compared to 49.5% for MannKind Corporation. Monte Rosa Therapeutics' share price is also noted as being more volatile than MannKind Corporation's.
From dailypolitical.com
Who's involved
- MannKind CorporationBiopharmaceutical company listed on Nasdaq
- Monte Rosa TherapeuticsBiotechnology company listed on Nasdaq
Keep exploring
The entities involved
-
MannKind Corporation
biopharmaceutical company
Nothing else this week.
-
Monte Rosa Therapeutics
biotechnology company